Παρακολούθηση
BIN YU, PhD, MRSC
BIN YU, PhD, MRSC
Full Professor of Medicinal Chemistry, College of Chemistry, Zhengzhou University
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα zzu.edu.cn - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Spirooxindoles: Promising scaffolds for anticancer agents
B Yu, DQ Yu, HM Liu
European Journal of Medicinal Chemistry 97, 673-698, 2015
8432015
LSD1/KDM1A inhibitors in clinical trials: Advances and prospects
Y Fang, G Liao*, B Yu*
Journal of Hematology & Oncology 12 (1), 129, 2019
3842019
Indoleamine 2,3-dioxygenase 1 (IDO1) inhibitors in clinical trials for cancer immunotherapy
K Tang, Y Wu, Y Song, B Yu*
Journal of Hematology & Oncology 14, 68, 2021
2772021
Discovery of orally active anticancer candidate CFI-400945 derived from biologically promising spirooxindoles: Success and challenges
B Yu, Z Yu, PP Qi, DQ Yu, HM Liu
European Journal of Medicinal Chemistry 95, 35-40, 2015
1682015
Targeting BRD4 for Cancer therapy: Inhibitors and Degraders
Y Duan, Y Guan, W Qin, X Zhai, B Yu*, HM Liu*
MedChemComm 9, 1779-1802, 2018
1522018
Targeting Epigenetic Regulators to Overcome Drug Resistance in Cancers
N Wang, T Ma*, B Yu*
Signal Transduction and Targeted Therapy 8, 69, doi: 10.1038/s41392-023-01341-7, 2023
1402023
Synthesis and biological evaluation of novel steroidal [17, 16-d][1, 2, 4] triazolo [1, 5-a] pyrimidines
LH Huang, YF Zheng, YZ Lu, CJ Song, YG Wang, B Yu, HM Liu
Steroids 77 (6), 710-715, 2012
1342012
Natural product-derived spirooxindole fragments serve as privileged substructures for discovery of new anticancer agents
B Yu, YC Zheng, XJ Shi, PP Qi, HM Liu
Anti-Cancer Agents in Medicinal Chemistry 16 (10), 1315-1324, 2016
1282016
Advances toward LSD1 inhibitors for cancer therapy
X Fu, P Zhang, B Yu
Future Medicinal Chemistry 9 (11), 1227-1242, 2017
1252017
Cancer nanotechnology: Enhancing tumor cell response to chemotherapy for hepatocellular carcinoma therapy
Y Sun, W Ma, Y Yang, M He, A Li, L Bai, B Yu, Z Yu
Asian Journal of Pharmaceutical Sciences 14 (6), 581-594, 2019
1162019
Irreversible LSD1 inhibitors: application of tranylcypromine and its derivatives in cancer treatment
Y C Zheng, B Yu, G Z Jiang, X J Feng, P X He, X Y Chu, W Zhao, H M Liu
Current topics in medicinal chemistry 16 (19), 2179-2188, 2016
1092016
FDA-approved pyrimidine-fused bicyclic heterocycles for cancer therapy: synthesis and clinical application
S Wang, XH Yuan, SQ Wang, W Zhao, XB Chen, B Yu*
European Journal of Medicinal Chemistry 214, 113218, 2021
1062021
Natural products as LSD1 inhibitors for cancer therapy
Y Fang, C Yang, Z Yu, X Li, Q Mu*, G Liao*, B Yu*
Acta Pharmaceutica Sinica B 11 (3), 621-631, 2021
992021
A Cell Membrane‐Targeting Self‐Delivery Chimeric Peptide for Enhanced Photodynamic Therapy and In Situ Therapeutic Feedback
W Ma, SN Sha, PL Chen, M Yu, JJ Chen, CB Huang, B Yu, Y Liu, LH Liu*, ...
Advanced Healthcare Materials, 1901100, 2019
992019
Synthesis and biological evaluation of coumarin–1, 2, 3-triazole–dithiocarbamate hybrids as potent LSD1 inhibitors
XW Ye, YC Zheng, YC Duan, MM Wang, B Yu, JL Ren, JL Ma, E Zhang, ...
MedChemComm 5 (5), 650-654, 2014
982014
The Development of Biologically Important Spirooxindoles as New Antimicrobial Agents
YT Yang, JF Zhu, G Liao, HJ Xu*, B Yu*
Current Medicinal Chemistry 25 (19), 2233-2244, 2018
972018
Small-molecule MDM2/X inhibitors and PROTAC degraders for cancer therapy: advances and perspectives
Y Fang, G Liao*, B Yu*
Acta Pharmaceutica Sinica B 10, 1253-1278, 2020
952020
Recent Progress in Histone Methyltransferase (G9a) Inhibitors as Anticancer Agents
H Cao, L Li, D Yang, L Zeng, Y Xie, B Yu*, G Liao*, J Chen*
European Journal of Medicinal Chemistry 179, 537-546, 2019
932019
Azvudine (FNC): A Promising Clinical Candidate for COVID-19 Treatment
B Yu, J Chang*
Signal Transduction and Targeted Therapy 5, 236, 2020
912020
The First Chinese Oral Anti-COVID-19 Drug Azvudine Launched
B Yu, J Chang*
The Innovation 3 (6), 100321, doi: 10.1016/j.xinn.2022.100321, 2022
872022
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20